2 Stocks That Could Capitalize on the GLP-1 Boom
Key PointsCVS Health is making it easier for patients to access GLP-1 drugs.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
More in Finance & Markets
Palantir Lost an $875 Million Contract. Is the Stock Still a Buy?
Palantir (NASDAQ: PLTR) lost a huge FAA contract, but its explosive commercial growth and improving earnings tell a more complicated story.
Canada's big banks are shrugging off Trump's trade war
Top executives at the Bank of Montreal and Scotiabank separately referred to the Canada-U.S. trade situation as "manageable" on Tuesday.
Canada's big banks are shrugging off Trump's trade war
Top executives at the Bank of Montreal and Scotiabank separately referred to the Canada-U.S. trade situation as "manageable" on Tuesday.
US-Canada Cosmetic Tariffs Threaten the $10 Beauty Impulse Buy
In between offering advice on how to find the best towels and where to buy affordable versions of high-end garments, Bryce Gruber recently waded into the US-Canada trade war, warning her social-media…
Explainer: What 2026 KRA tax amnesty means for businesses and employees
Businesses and employees with old tax problems have until December 31, 2026, to clear qualifying liabilities and have related interest, penalties and fines waived under a new Kenya Revenue Authority…
South Korea trade giant POSCO brings trade receivables to Avalanche in latest tokenization move
The $22 billion trading company worked with Olea and Intain on the transaction, following an Injective pilot with LG CNS last month.